NEWS
‘Spring tiredness’ can be the first sign of serious illness
The 30th of May is marked as World Multiple Sclerosis Day. It brings the global MS community together to share stories, raise awareness and campaign with everyone affected by MS. As a part of the world health community, Norameda wants to share the insights of our dear...
Norameda’s sales grow steadily every year
Norameda, a leading pharmaceutical company in Baltic countries, announced a 3.2% growth in sales last year. Norameda's turnover is growing steadily every year, and in 2022 was 26,6M, 2021 - 25,8M, and 22,9M in 2020. "We are pleased with the results in all our...
World Parkinson’s Disease Day ’23 and new hope for patients in Lithuania
Approximately 8,5 million people have Parkinson's disease worldwide and ~1.2 million in Europe. Globally, disability and death due to PD are increasing faster than any other neurological disorder. The prevalence of PD has doubled in the past 25 years. Lithuania has...
Challenges of the Polish pharmaceutical market: inflation raises the value, but many problems still need to be addressed
Lithuanian capital pharmaceutical company Norameda opened a branch and e-pharmacy in Poland almost two years ago. According to the CEO of Norameda of the Polish Branch, Arvydas Norvaišas, the market in the neighbouring country is challenging but still appealing....